Atrial Fibrillation (AF), the most common type of abnormal heart rhythm, is a preventable cause of stroke, but its identification and management is not well developed in primary care. CD&D are seeking to highlight the importance of AF, and to set out the interventions that will increase early detection and treatment to reduce the risk of stroke.
Having worked with The National Heart Improvement Priority Project, CD&D identified the patients in local practices with a high risk of developing a stroke caused by AF. From the 23 practices involved, only 55% of high risk patients were currently receiving preventative treatment for their condition. Based on these figures, CD&D needed to estimate the resources required to extend anticoagulation treatment to these other patients, and what the overall cost impact this would have for the NHS.
Scenario Generator is visual simulation software which allows NHS staff to test out real life scenarios in a risk free environment and, using its statistically accurate results, make evidence based decisions as to which changes will help an organisation the most. The software comes embedded with up-to-date population and disease prevalence data, allowing users to gain true insight into the effect changes will have. CD&D used Scenario Generator to model the path of care these patients currently follow, and tested ‘what if?’ scenarios to see the impact different methods of treatments would have.
The results of the analysis and modelling proved that while treating new patients with a mixture of preventative drugs would cost an extra £415,615 in the first year, treating all new patients with Warfarin, would save the NHS £352,414 by preventing strokes and related complications. By year five, CD&D could save over £1m simply by choosing the best pathway and treatment course as demonstrated by Scenario Generator.
“The main benefit of Scenario Generator has been the flexibility to modify the model as the project has developed,” says Dr. Mike Lavendar, Consultant in Public Health Medicine at CD&D, “We have been able to tackle different questions by adding additional elements to the pathway.
About SIMUL8 Corporation
SIMUL8 Corporation produces world renowned dynamic, innovative software that enhances the way people make and communicate decisions. With headquarters in Boston, MA, and offices in the UK, our customers are located world-wide and include major corporations involved in finance, manufacturing, healthcare, telecommunications and logistics, as well as many public sector healthcare and transportation bodies. Our software allows organizations to identify and test the benefit of potential improvement proposals, prior to their implementation, in a risk-free environment.